We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hipgnosis Songs Fund Limited | LSE:SONG | London | Ordinary Share | GG00BFYT9H72 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 100.80 | 100.80 | 101.20 | 101.20 | 100.40 | 100.40 | 2,413,518 | 13:55:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 177.31M | -89.64M | -0.0741 | -13.63 | 1.22B |
TIDMSONG
RNS Number : 6856M
Hipgnosis Songs Fund Limited
10 January 2019
10 January 2019
Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")
Portfolio Update
The Board of Hipgnosis Songs Fund Limited and its Investment Adviser, The Family (Music) Limited, are pleased to announce that the Company has acquired six music catalogues since its IPO in July 2018.
The catalogues acquired to date comprise 1,230 songs in total. The songs in the portfolio have achieved 1,646 Top 10 chart positions around the world including 402 Number 1's. 20 songs were Number 1's in both the US and UK with over 107 Top 10 chart positions in those markets, many of which are Grammy Award winners or nominees. The catalogues acquired to date comprise songs written for more than 100 recording artists.
While the Company is constrained by confidentiality undertakings as to disclosing the valuation multiples paid for each catalogue, a total of GBP73.0 million has now been invested on an aggregate multiple of 12.2x historic annual net income. The Company's target returns, as set out in its IPO prospectus, remain unchanged.
For further information, please contact:
The Family (Music) Limited Tel: +44 (0)1481 742742 Merck Mercuriadis N+1 Singer Tel: +44 (0)20 7496 James Maxwell / James Moat (Corporate 3000 Finance) Alan Geeves / James Waterlow / Sam Greatrex (Sales) The Outside Organisation Tel: +44 (0)7711 081 Alan Edwards / Nick Caley 843
NOTES TO EDITORS
About Hipgnosis Songs Fund Limited
(www.hipgnosissongs.com)
Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. In its Initial Public Offering on the Specialist Fund Segment of the London Stock Exchange's main market on 11 July 2018, the Company raised approximately GBP200m gross equity capital.
About The Family (Music) Limited
The Company's Investment Adviser is The Family (Music) Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of The Family (Music) Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Bill Leibowitz, Ian Montone, and Jason Flom.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
PFUDDGDBSUGBGCC
(END) Dow Jones Newswires
January 10, 2019 02:00 ET (07:00 GMT)
1 Year Hipgnosis Songs Chart |
1 Month Hipgnosis Songs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions